| abstract |
The present invention relates to compositions comprising cannabidiol (CBD) or pharmaceutically acceptable salts thereof, and bacitracin or pharmaceutically acceptable salts thereof and / or daptomycin or pharmaceutically acceptable salts thereof . These compositions have a synergistic effect in inhibiting the growth of Gram-positive bacteria. Thus, the compositions according to the invention can, e.g. eg, be used as drugs in the treatment of Gram-positive bacterial infections. |